Dr. Carissa James ’14 of FirstString Research, Inc.
Alternative Translation as a Novel Cellular Regulator of Gap Junctional Coupling
Monday, January 27, 2020 – 12:00-12:50 pm – RITA 102
Dr. James is a former research student of Dr. Meyer-Bernstein and an excellent speaker. She obtained her PhD in Translational Biology, Medicine, and Health in 2019 from Virginia Tech and recently started a job as a Translational Scientist at First String Research in Mount Pleasant. Biology and Biochemistry students are strongly encouraged to attend.
Gap junctions, comprised of connexin proteins,are essential for direct intercellular electrical, metabolic, and immunological coupling. Connexin43 (Cx43, gene name GJA1) is the most ubiquitously expressed gap junction protein, and Cx43 gap junctions are altered in pathological states including cardiac disease and cancer. The GJA1 mRNA undergoes alternative translation initiation to yield a truncated Cx43 isoform, GJA1-20k, that can regulate gap junction formation. Using epithelial-mesenchymal transition (EMT) as a cellular model of gap junction remodeling, we have demonstrated altered translation initiation of Gja1 as a mechanism by which cellular Cx43 gap junctions can be dynamically regulated. Suppression of Gja1 alternative translation is necessary for Cx43 gap junction loss, and stable expression of GJA1-20k rescues gap junction formation during EMT. To identify regulatory factors acting on the Gja1 mRNA, an MS2 RNA aptamer tagging system was adapted to isolate Gja1 with associated RNA binding proteins. We find the RNA binding protein IMP1 is sensitive to hypoxic stress and complexes with Gja1 mRNA, where it is necessary for alternative translation to generate GJA1-20k. We have demonstrated alterations in translation initiation of the Gja1 mRNA as a critical mechanism by which cells modulate Cx43 gap junctional coupling in changing conditions and identified a novel regulator of this process in mammalian cells.